Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential information.
This rejection became public following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesman later explained that the United States was demanding access to genetic material for research and commercial purposes while refused to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to reach a deal agreeable to all parties so the country's critical HIV programme can continue.
Wider Context
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our people should a future pandemic emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks previously set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We are open to further dialogue with our US partners on how future co-operation might be arranged in a way that honours the independence and interests of each country."
Medical Community Reaction
A leading public health body expressed it understood the official position, but suggested that talks must proceed since much of the nation's Aids initiatives were funded by international support.
"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it added.
The situation underscores the ongoing debate between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.